Sofinnova Ventures
Latest statistics and disclosures from Sofinnova Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NTRA, VERA, ASND, AVTE, MRK, and represent 31.94% of Sofinnova Investments's stock portfolio.
- Added to shares of these 10 stocks: XBI (+$81M), NVO (+$79M), INCY (+$76M), PODD (+$38M), DYN (+$36M), ALGN (+$31M), Arrivent Biopharma (+$30M), TGTX (+$30M), ARGX (+$28M), BSX (+$24M).
- Started 38 new stock positions in BSX, ROIV, SWAV, INSP, EXAS, MDGL, KURA, LIVN, ESTA, NARI.
- Reduced shares in these 10 stocks: Karuna Therapeutics Ord (-$234M), NTRA (-$142M), Rayzebio (-$54M), AZN (-$52M), DXCM (-$51M), CYTK (-$46M), IWM (-$40M), , , KVUE (-$36M).
- Sold out of its positions in AGEN, AXSM, Cymabay Therapeutics, CYTK, DXCM, EXEL, GRTX, GERN, ImmunoGen, IMVT.
- Sofinnova Investments was a net seller of stock by $-308M.
- Sofinnova Investments has $1.8B in assets under management (AUM), dropping by 13.24%.
- Central Index Key (CIK): 0001631134
Tip: Access up to 7 years of quarterly data
Positions held by Sofinnova Ventures consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 69 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Natera (NTRA) | 7.9 | $142M | -50% | 1.6M | 91.46 |
|
| Vera Therapeutics Cl A (VERA) | 6.7 | $121M | -19% | 2.8M | 43.12 |
|
| Ascendis Pharma A/S Sponsored Adr (ASND) | 6.3 | $114M | 754k | 151.17 |
|
|
| Aerovate Therapeutics (AVTE) | 6.2 | $111M | 3.8M | 29.57 |
|
|
| Merck & Co (MRK) | 4.8 | $86M | -10% | 651k | 131.95 |
|
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 4.5 | $81M | NEW | 850k | 94.89 |
|
| Novo-Nordisk A S Adr (NVO) | 4.4 | $79M | NEW | 612k | 128.40 |
|
| Incyte Corporation (INCY) | 4.2 | $76M | NEW | 1.3M | 56.97 |
|
| Argenx SE Sponsored Adr (ARGX) | 3.3 | $59M | +90% | 149k | 393.72 |
|
| Intuitive Surgical (ISRG) | 3.1 | $56M | -18% | 141k | 399.09 |
|
| Dyne Therapeutics (DYN) | 3.1 | $55M | +182% | 1.9M | 28.39 |
|
| Inhibrx (INBX) | 2.5 | $46M | +75% | 1.3M | 34.96 |
|
| Elanco Animal Health (ELAN) | 2.3 | $42M | -29% | 2.6M | 16.28 |
|
| IDEXX Laboratories (IDXX) | 2.3 | $41M | -3% | 75k | 539.93 |
|
| AstraZeneca Sponsored Adr (AZN) | 2.3 | $40M | -56% | 597k | 67.75 |
|
| Syndax Pharmaceuticals (SNDX) | 2.1 | $38M | -19% | 1.6M | 23.80 |
|
| Insulet Corporation (PODD) | 2.1 | $38M | NEW | 220k | 171.40 |
|
| Y Mabs Therapeutics (YMAB) | 2.0 | $36M | 2.2M | 16.26 |
|
|
| Ideaya Biosciences (IDYA) | 1.9 | $34M | -24% | 782k | 43.88 |
|
| Celldex Therapeutics (CLDX) | 1.9 | $34M | +28% | 802k | 41.97 |
|
| Inozyme Pharma (INZY) | 1.8 | $33M | 4.3M | 7.66 |
|
|
| Align Technology (ALGN) | 1.7 | $31M | NEW | 96k | 327.92 |
|
| Arrivent Biopharma | 1.7 | $30M | NEW | 1.7M | 17.86 |
|
| Tg Therapeutics (TGTX) | 1.7 | $30M | NEW | 2.0M | 15.21 |
|
| Sarepta Therapeutics (SRPT) | 1.6 | $30M | +345% | 228k | 129.46 |
|
| Marinus Pharmaceuticals (MRNS) | 1.6 | $29M | +149% | 3.3M | 9.04 |
|
| Boston Scientific Corporation (BSX) | 1.4 | $24M | NEW | 354k | 68.49 |
|
| Immatics NV SHS (IMTX) | 1.3 | $23M | -33% | 2.2M | 10.51 |
|
| Silk Road Medical Inc Common (SILK) | 1.2 | $22M | NEW | 1.2M | 18.32 |
|
| Cogent Biosciences (COGT) | 0.9 | $16M | NEW | 2.4M | 6.72 |
|
| EXACT Sciences Corporation (EXAS) | 0.9 | $16M | NEW | 230k | 69.06 |
|
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $15M | NEW | 103k | 149.45 |
|
| Immunome (IMNM) | 0.8 | $15M | NEW | 594k | 24.68 |
|
| Pharvaris N V (PHVS) | 0.8 | $14M | NEW | 585k | 23.11 |
|
| Savara (SVRA) | 0.7 | $12M | +1386% | 2.3M | 4.98 |
|
| Shockwave Med (SWAV) | 0.6 | $11M | NEW | 35k | 325.63 |
|
| Kura Oncology (KURA) | 0.6 | $11M | NEW | 502k | 21.33 |
|
| Roivant Sciences SHS (ROIV) | 0.6 | $11M | NEW | 1.0M | 10.54 |
|
| Axonics Modulation Technolog (AXNX) | 0.6 | $10M | NEW | 149k | 68.97 |
|
| Pepgen (PEPG) | 0.4 | $7.4M | NEW | 504k | 14.70 |
|
| Cabaletta Bio (CABA) | 0.4 | $7.3M | NEW | 430k | 17.06 |
|
| Establishment Labs Holdings Ord (ESTA) | 0.4 | $7.2M | NEW | 141k | 50.90 |
|
| Achieve Life Sciences (ACHV) | 0.4 | $6.9M | NEW | 1.5M | 4.54 |
|
| Soleno Therapeutics (SLNO) | 0.4 | $6.5M | NEW | 151k | 42.80 |
|
| 4d Molecular Therapeutics In (FDMT) | 0.4 | $6.3M | NEW | 198k | 31.86 |
|
| Nextcure (NXTC) | 0.3 | $6.0M | 2.7M | 2.23 |
|
|
| Avantor (AVTR) | 0.3 | $5.9M | NEW | 232k | 25.57 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.3 | $5.1M | NEW | 19k | 267.04 |
|
| Bolt Biotherapeutics (BOLT) | 0.2 | $3.9M | 2.8M | 1.40 |
|
|
| Fusion Pharmaceuticals (FUSN) | 0.2 | $3.4M | +34% | 157k | 21.32 |
|
| Masimo Corporation (MASI) | 0.2 | $2.9M | NEW | 20k | 146.85 |
|
| Teleflex Incorporated (TFX) | 0.2 | $2.7M | NEW | 12k | 226.17 |
|
| Insmed Com Par $.01 Call Option (INSM) | 0.2 | $2.7M | NEW | 100k | 27.13 |
|
| Cooper Cos (COO) | 0.1 | $2.2M | NEW | 21k | 101.46 |
|
| Inspire Med Sys (INSP) | 0.1 | $1.7M | NEW | 8.1k | 214.79 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.1 | $1.7M | NEW | 607k | 2.84 |
|
| LivaNova SHS (LIVN) | 0.1 | $1.1M | NEW | 21k | 55.94 |
|
| Nucana Sponsored Adr (NCNA) | 0.0 | $884k | -39% | 3.4M | 0.26 |
|
| Baxter International (BAX) | 0.0 | $855k | NEW | 20k | 42.74 |
|
| Immatics NV *w Exp 07/01/2025 (IMTXW) | 0.0 | $853k | 316k | 2.70 |
|
|
| Pds Biotechnology Ord (PDSB) | 0.0 | $565k | 143k | 3.96 |
|
|
| IsoRay (CATX) | 0.0 | $512k | NEW | 430k | 1.19 |
|
| Inari Medical Ord (NARI) | 0.0 | $490k | NEW | 10k | 47.98 |
|
| Disc Medicine (IRON) | 0.0 | $384k | NEW | 6.2k | 62.26 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $374k | -95% | 8.7k | 42.86 |
|
| Nucana Common Shares | 0.0 | $340k | -45% | 1.3M | 0.26 |
|
| Kyverna Therapeutics | 0.0 | $248k | NEW | 10k | 24.84 |
|
| Ikena Oncology (IKNA) | 0.0 | $164k | 116k | 1.42 |
|
|
| Mirum Pharmaceuticals (MIRM) | 0.0 | $76k | -66% | 3.0k | 25.12 |
|
Past Filings by Sofinnova Investments
SEC 13F filings are viewable for Sofinnova Investments going back to 2018
- Sofinnova Investments 2024 Q1 filed May 15, 2024
- Sofinnova Investments 2023 Q3 filed Nov. 14, 2023
- Sofinnova Investments 2023 Q2 filed Aug. 14, 2023
- Sofinnova Investments 2023 Q1 filed May 11, 2023
- Sofinnova Investments 2022 Q4 filed Feb. 14, 2023
- Sofinnova Investments 2022 Q3 filed Nov. 8, 2022
- Sofinnova Investments 2022 Q2 filed Aug. 15, 2022
- Sofinnova Investments 2022 Q1 filed May 16, 2022
- Sofinnova Investments 2021 Q4 filed Feb. 14, 2022
- Sofinnova Investments 2021 Q3 filed Nov. 15, 2021
- Sofinnova Investments 2021 Q2 filed Aug. 16, 2021
- Sofinnova Investments 2021 Q1 filed May 14, 2021
- Sofinnova Investments 2020 Q4 filed Feb. 16, 2021
- Sofinnova Investments 2020 Q3 filed Nov. 13, 2020
- Sofinnova Investments 2020 Q2 filed Aug. 13, 2020
- Sofinnova Investments 2020 Q1 filed May 13, 2020